Citations

Mayo Clinic

Showing 10 of 108599 citations.

Transition of Intravenous Treprostinil to Oral Therapy in a Patient with Functional Class IV Chronic Thromboembolic Pulmonary Hypertension
Thurber, Kristina M., Williams, Breann M., Bates, Ruth , Frantz, Robert P. , Bates, Ruth E, Frantz, Robert P

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | May 17, 2017 | Volume: 37 | Issue: 8 | Pages: No page available

10.1002/phar.1951 | PMID 28513869 Get It

Chronic thromboembolic pulmonary hypertension (CTEPH) occurs when pulmonary emboli fail to resolve with anticoagulation. For patients with inoperable or residual CTEPH, riociguat is currently the only therapy approved by the United States Food and Drug Administration. However, some patients with CTEPH may require therapy beyond riociguat, such as intravenous prostacyclins, which can present significant administration challenges in patients with complex comorbid conditions. We describe a 42‐year‐old man with T12 paraplegia complicated by CTEPH (functional class IV with substantial right ventricular dysfunction) and severe pressure ulcers. In order to facilitate goals of care (hospital discharge to a skilled nursing facility where parenteral prostanoids could not be administered), he underwent rapid transition from intravenous treprostinil to oral selexipag in the form of a cross‐taper over 6 days. The patient required readmission due to worsening symptoms and was transitioned back to intravenous treprostinil; he tolerated conversion to oral treprostinil for approximately 4 months, but it was subsequently discontinued due to nausea and modified goals of care. The patient underwent transition to hospice care 3 months later and eventually died from clinical deterioration. To our knowledge, this is the first report to describe transition from intravenous treprostinil to selexipag as well as conversion from parenteral treprostinil to oral treprostinil in a patient with CTEPH and illustrates the approaches to and potential issues with prostanoid transitions. Additional observations are necessary to better understand the relative roles of selexipag and oral treprostinil regarding comparative efficacy and tolerability.
Modular Fluted Tapered Stems in Aseptic Revision Total Hip Arthroplasty
Cottino, Umberto , Hanssen, Arlen D. , Lewallen, David G. , Berry, Daniel J. , Abdel, Matthew P. , Larson, Dirk R. , Berry, Daniel J

Journal of Bone and Joint Surgery | May 17, 2017 | Volume: 99 | Issue: 10 | Pages: 873-881

10.2106/jbjs.16.00423 | PMID 28509828 Get It

Background: Modular fluted tapered stems have become the most commonly employed category of femoral component in revision hip arthroplasty in North America as a result of favorable early results and simplicity of use. Despite wide adoption, the majority of published data are limited to relatively small series with modest follow-up. The goal of the current study was to determine the success rate and factors associated with success, failure, and complications of the use of modular fluted tapered stems in aseptic revision total hip arthroplasties (THAs) in a large patient cohort. Methods: We identified 519 aseptic femoral revisions during which a modular fluted tapered stem was utilized. Clinical outcomes, Kaplan-Meier survivorship, radiographic outcomes, and complications were assessed. The mean age at revision arthroplasty was 70 years, the mean body mass index (BMI) was 29 kg/m 2 , and the mean duration of follow-up was 4.5 years (range, 2 to 14 years). Results: The mean Harris hip score (HHS) improved significantly from 51 points preoperatively to 76 points at 2 years (p < 0.001). This improvement was maintained at the last follow-up evaluation (mean HHS = 75 points). At the time of the most recent follow-up, 16 femoral revisions had been performed: 6 because of aseptic loosening, 4 because of infection, 3 because of instability, 2 because of periprosthetic fracture, and 1 because of stem fracture. The 10-year survivorship was 96% with revision for any reason as the end point and 90% with any reoperation as the end point. Of the patients who were alive and had not undergone revision at the time of final follow-up, 12 had stem subsidence but all but 1 of these stems had stabilized after subsiding. Postoperative complications were noted in 12% of the cases. Repeat revision due to femoral component loosening was not correlated with the preoperative bone-loss category or patient demographic factors. Conclusions: In this large series, femoral revision with a modular fluted tapered stem provided a high rate of osseointegration and sustained improvement in clinical scores at the time of the last follow-up. There was also a high rate of successful implant fixation across all categories of preoperative bone loss and an acceptable rate of complications. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
Minimum Five-Year Outcomes with Porous Tantalum Acetabular Cup and Augment Construct in Complex Revision Total Hip Arthroplasty
Jenkins, Derek , Odland, Andrew N., Hanssen, Arlen D. , Lewallen, David G. , Jenkins, Derek R, Sierra, Rafael J.

Journal of Bone and Joint Surgery | May 17, 2017 | Volume: 99 | Issue: 10 | Pages: e49

10.2106/jbjs.16.00125 | PMID 28509833 Get It

Background: The use of a trabecular metal revision shell with metal augmentation to fill segmental or irregular defects during complex revision hip arthroplasty has been shown to provide good short-term results in prior published series. Longer-term results of the several cup-augment constructs used clinically are not known. The objective of this study was to report, with minimum 5-year radiographic and clinical follow-up, the outcome of these various constructs in revision total hip arthroplasty. Methods: Eighty-four patients (85 hips) underwent revision total hip arthroplasty with use of porous tantalum augments between 2000 and 2007 at a single institution and were retrospectively reviewed. Fifty-seven of the patients (58 hips) had clinical and radiographic follow-up at a minimum of 5 years. At the time of revision, the majority of the hips had acetabular defects classified as Paprosky Type 3A (28 of 58, 48%) or Type 3B (22 of 58, 38%). Eleven (19%) of the hips also had preoperative pelvic discontinuity. All hips were assessed clinically at a minimum of 5 years with use of the Mayo hip score. Postoperative radiographs were reviewed for implant stability, the presence and location of radiolucent lines and healing of the discontinuity if present. Results: In 2 (3%) of the 58 hips, the constructs failed because of aseptic loosening of the acetabular component and re-revision was indicated. Six (10%) of the 58 hips demonstrated a radiolucent line between the trabecular metal shell and bone in DeLee and Charnley zone 3. In 1 hip that underwent re-revision and in 5 of the 6 hips with a zone-3 radiolucency, a pelvic discontinuity was present at the time of the index revision. The mean preoperative Mayo hip score was 35.7, which improved to 61.9 at 3 months and was 61.7 at the minimum 5-year follow-up. Conclusions: With failure defined as aseptic loosening requiring repeat revision surgery, this cohort demonstrated 97% survivorship and maintained satisfactory hip function at the minimum 5 years after the index revision surgery. Six of the 11 hips with preoperative pelvic discontinuity either failed or developed a radiolucency in zone 3 and are considered at risk for future revision. Pelvic discontinuity should prompt consideration of the addition of adjunctive fixation or the use of alternative techniques. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
Faculty Opinions recommendation of Coupled proliferation and apoptosis maintain the rapid turnover of microglia in the adult brain.
Wu, Long‐Jun , Eyo, Ukpong B

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | May 17, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.727193225.793531658 Get It

An unusual case of methicillin‐resistant Staphylococcus aureus necrotic soft tissue infection of the lip
Kamboj, Amrit K. , Cotter, Thomas G. , McEvoy, Marian T., Davis, Mark Denis D., Miller, Donna , Davis, Mark D., Miller, Donna M, Miller, Donna M , Cotter, T G

International Journal of Dermatology | May 17, 2017 | Volume: 56 | Issue: 12 | Pages: 1475-1477

10.1111/ijd.13630 | PMID 28512754 Get It

Cybersecurity and medical devices: A practical guide for cardiac electrophysiologists
Ransford, Benjamin, Kramer, Daniel B. , Kune, Denis Foo, Medeiros, Julio Auto de, Crawford, Thomas , Fu, Kevin , Auto de Medeiros, Julio, Chen, Yan , Xu, Wenyuan

Pacing and Clinical Electrophysiology | May 17, 2017 | Volume: 40 | Issue: 8 | Pages: 913-917

10.1111/pace.13102 | PMID 28512774 Get It

AbstractMedical devices increasingly depend on software. While this expands the ability of devices to perform key therapeutic and diagnostic functions, reliance on software inevitably causes exposure to hazards of security vulnerabilities. This article uses a recent high‐profile case example to outline a proactive approach to security awareness that incorporates a scientific, risk‐based analysis of security concerns that supports ongoing discussions with patients about their medical devices.
Technique for Primary and Redo Surgery for Peroneal Intraneural Ganglion Cysts
Wilson, Thomas J. , Rock, Michael G., Spinner, Robert J.

Operative Neurosurgery | May 17, 2017 | Volume: 14 | Issue: 2 | Pages: 208-208

10.1093/ons/opx114 | PMID 28520989 Get It

REM S leep B ehavior D isorder in P arkin
Louis, Erik K. St. , Boeve, Angelica, St Louis, Erik K, Boeve, Angelica R, Boeve, Bradley F. , St Louis, E K

Movement Disorders | May 17, 2017 | Volume: 32 | Issue: 5 | Pages: 645-658

10.1002/mds.27018 | PMID 28513079 Get It

ABSTRACT Rapid eye movement sleep behavior disorder is characterized by dream enactment and complex motor behaviors during rapid eye movement sleep and rapid eye movement sleep atonia loss (rapid eye movement sleep without atonia) during polysomnography. Rapid eye movement sleep behavior disorder may be idiopathic or symptomatic and in both settings is highly associated with synucleinopathy neurodegeneration, especially Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. Rapid eye movement sleep behavior disorder frequently manifests years to decades prior to overt motor, cognitive, or autonomic impairments as the presenting manifestation of synucleinopathy, along with other subtler prodromal “soft” signs of hyposmia, constipation, and orthostatic hypotension. Between 35% and 91.9% of patients initially diagnosed with idiopathic rapid eye movement sleep behavior disorder at a sleep center later develop a defined neurodegenerative disease. Less is known about the long‐term prognosis of community‐dwelling younger patients, especially women, and rapid eye movement sleep behavior disorder associated with antidepressant medications. Patients with rapid eye movement sleep behavior disorder are frequently prone to sleep‐related injuries and should be treated to prevent injury with either melatonin 3‐12 mg or clonazepam 0.5‐2.0 mg to limit injury potential. Further evidence‐based studies about rapid eye movement sleep behavior disorder are greatly needed, both to enable accurate prognostic prediction of end synucleinopathy phenotypes for individual patients and to support the application of symptomatic and neuroprotective therapies. Rapid eye movement sleep behavior disorder as a prodromal synucleinopathy represents a defined time point at which neuroprotective therapies could potentially be applied for the prevention of Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. © 2017 International Parkinson and Movement Disorder Society
The Renal–Cardiac Connection in Subjects with Preserved Ejection Fraction: A Population Based Study
Jain, Amit Kumar C , Chen, Horng H. , Scott, Christopher G.

ESC Heart Failure | May 17, 2017 | Volume: 4 | Issue: 3 | Pages: 266-273

10.1002/ehf2.12143 | PMID 28772030 Get It

Abstract Aims Chronic kidney disease (CKD) is prevalent and is associated with increased cardiovascular morbidity and mortality. The interaction between diastolic dysfunction (DD) and CKD in subjects with preserved systolic function is not well defined. This study sought to determine the association between renal function and DD in subjects with preserved ejection fraction. Methods and results Through the Rochester Epidemiology Project, subjects who underwent echocardiography over 2 years with EF ≥50% were identified and the clinical data were obtained. Glomerular filtration rate (GFR) was estimated using the modification of diet in renal disease equation. Linear regression was used to test for association of GFR and DD. DD was defined as follows: Grade 2 or pseudonormal pattern (0.75 &lt; E/A ≤ 1.5, E/e′ ≥ 10, DT &gt; 140 ms, ΔE/A ≥ 0.5, and PV S &lt; D) or Grade 3+ or restrictive pattern (E/A &gt; 1.5, E/e′ ≥ 10, DT &lt; 140 ms, and PV S &lt; D). Cox regression was used to assess correlation of GFR and DD with time-to-event outcomes. A total of 2056 patients were identified. There was significant correlation between worsening GFR and degree of DD assessed by echo Doppler E/e′ ratio (P = 0.005), left ventricular mass index (P = 0.004), and right ventricular systolic pressure (P = 0.01). Worsening GFR was associated with increased mortality, development of heart failure, and hospitalization (P &lt; 0.001). Within each GFR group, abnormal DD was associated with a higher risk of the clinical outcomes. No interaction between GFR and DD was noted, suggesting an increased risk of events associated with abnormal DD across ranges of GFR. Conclusions Worsening GFR was associated with a greater degree of diastolic dysfunction and adverse clinical outcomes. Within each GFR group, the presence of DD was associated with increased morbidity and mortality. Further studies are warranted to determine if improving DD in patients with CKD will benefit clinical outcomes.
Negative Cardiovascular Consequences of Small Molecule Immunosuppressants
Chakkera, Harini A. , Sharif, Adnan , Kaplan, Bruce , Chakkera, Harini A

Clinical Pharmacology & Therapeutics | May 16, 2017 | Volume: 102 | Issue: 2 | Pages: 269-276

10.1002/cpt.738 | PMID 28512771 Get It

Immunosuppressants are critical after transplantation and prescribed as immune‐modulators for autoimmune disorders and glomerulonephritides. Immunosuppressants include large (e.g., thymoglobulin, alemtuzumab, and rituximab) and small molecules (e.g., corticosteroids, calcineurin inhibitors, antimetabolites, and mammalian target of rapamycin (mTOR) inhibitors). The majority of the small molecules worsen traditional cardiovascular risks. This review describes cardiovascular risks of small molecule immunosuppressants: corticosteroids, calcineurin inhibitors (tacrolimus and cyclosporine), and mTOR inhibitors (rapamycin), by categorizing these risks into two categories: ischemic heart disease and nonischemic cardiac effects.